Trial Profile
Real-World, long term Safety of Adalimumab in Rheumatoid Arthritis patients from the Corrona RA registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Aug 2019
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Prednisone
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 01 Aug 2019 Results published in The Journal of Rheumatology
- 21 Nov 2018 New trial record
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting